{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": {
    "pdf_name": "CDC_Influenza_vaccines",
    "source_pdf": "data/clinical_files/CDC Influenza vaccines.pdf",
    "total_pages": 2,
    "total_blocks": 20,
    "total_characters": 2329
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 1,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "that any influenza vaccine (egg based or non egg based) that is otherwise appropriate for the recipient's age and health status can be used (see Persons with a History of Egg Allergy).",
      "relevance_explanation": "This quote distinguishes between egg-based and non-egg-based (cell-based or recombinant) influenza vaccines, which is relevant context for discussing differences in production methods and potential for mutations. However, it does not directly address mutations or effectiveness."
    }
  ],
  "model_used": "gpt-4.1"
}